<DOC>
	<DOCNO>NCT01483833</DOCNO>
	<brief_summary>To evaluate safety efficacy topical 0.5 % S-MPEC cream vs. placebo cream ( applied twice daily 14 day ) treatment Grade I - III hemorrhoid .</brief_summary>
	<brief_title>Efficacy Study Iferanserin Treat Hemorrhoids</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhoids</mesh_term>
	<criteria>Age 18 year old Diagnosis grade I III hemorrhoid bleed episode least every day last two week enrollment study . Patients sign Informed Consent form . Patients protrude irreducible hemorrhoid ( grade IV ) . Patients anal fistula , periproctitis hemorrhagic diathesis Patients current history Type I Type II diabetes mellitus . Patients severe hepatic , renal cardiovascular disorder . Patients type infectious disease . Patients involve another experimental drug trial within past 30 day . Patients presently diagnose cancer . Patients know alcohol drug abuse . Patients require use suppository . Patients blood urine laboratory value outside normal limit value consider abnormal opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>